Embla Medical hf Management

Management criteria checks 3/4

Embla Medical hf's CEO is Sveinn Solvason, appointed in Apr 2022, has a tenure of 2.67 years. total yearly compensation is $1.18M, comprised of 48.8% salary and 51.2% bonuses, including company stock and options. directly owns 0.016% of the company’s shares, worth $340.49K. The average tenure of the management team and the board of directors is 2.5 years and 15.9 years respectively.

Key information

Sveinn Solvason

Chief executive officer

US$1.2m

Total compensation

CEO salary percentage48.8%
CEO tenure2.7yrs
CEO ownership0.02%
Management average tenure2.5yrs
Board average tenure15.9yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Sveinn Solvason's remuneration changed compared to Embla Medical hf's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$69m

Jun 30 2024n/an/a

US$61m

Mar 31 2024n/an/a

US$57m

Dec 31 2023US$1mUS$576k

US$58m

Sep 30 2023n/an/a

US$52m

Jun 30 2023n/an/a

US$45m

Mar 31 2023n/an/a

US$43m

Dec 31 2022US$780kUS$409k

US$43m

Compensation vs Market: Sveinn's total compensation ($USD1.18M) is below average for companies of similar size in the US market ($USD5.35M).

Compensation vs Earnings: Sveinn's compensation has increased by more than 20% in the past year.


CEO

Sveinn Solvason (46 yo)

2.7yrs

Tenure

US$1,180,000

Compensation

Mr. Sveinn Solvason had been Chief Financial Officer of Embla Medical hf. (formerly known as ssur hf.) since May 2013 until April 1, 2022 and serves as its President & CEO since April 1, 2022.Mr. Solvaso...


Leadership Team

NamePositionTenureCompensationOwnership
Sveinn Solvason
President & CEO2.7yrsUS$1.18m0.016%
$ 340.5k
Ossur Kristinsson
Founderno dataUS$25.00kno data
Gudny Sveinsdottir
Chief Financial Officer2.3yrsno datano data
Lukas Marklin
Chief Operating Officer1.5yrsno datano data
Edda Luovigsdottir
Investor Relations Directorno datano datano data
Margret Fridriksdottir
Executive Vice President of Peopleno dataUS$242.00k0.0083%
$ 176.3k
Olafur Gylfason
Executive Vice President of Chronic Solutionsno dataUS$600.00k0.0030%
$ 63.8k
Christian Robinson
President of Americasno datano data0.0031%
$ 65.7k
Hildur Einarsdottir
Executive Vice President of Research & Development2.7yrsno data0.00014%
$ 3.0k

2.5yrs

Average Tenure

48yo

Average Age

Experienced Management: OSSF.F's management team is considered experienced (2.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Niels Jacobsen
Chairman of the Board19.9yrsUS$108.00k0.048%
$ 1.0m
Svafa Gronfeldt
Vice Chairman of the Board16.9yrsUS$72.00kno data
Gudbjorg Eggertsdottir
Independent Director11.8yrsUS$43.00k0.0062%
$ 131.0k
Arne Nielsen
Director15.9yrsUS$50.00kno data
Alberto Esquenazi
Independent Director3.8yrsUS$43.00kno data

15.9yrs

Average Tenure

67yo

Average Age

Experienced Board: OSSF.F's board of directors are seasoned and experienced ( 15.9 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 21:56
End of Day Share Price 2024/12/09 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Embla Medical hf. is covered by 12 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Morten LarsenABG Sundal Collier
Benjamin SilverstoneABG Sundal Collier Sponsored
null nullABG Sundal Collier Sponsored